You are here

  • Home
  • Archive
  • Volume 68, Issue 12
  • Systemic tryptophan and kynurenine catabolite levels relate to severity of rhinovirus-induced asthma exacerbation: a prospective study with a parallel-group design

Article info

Article menu
Biomarkers of disease
Original article
Systemic tryptophan and kynurenine catabolite levels relate to severity of rhinovirus-induced asthma exacerbation: a prospective study with a parallel-group design
Free

Authors

  • Koenraad F van der Sluijs Department of Respiratory Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The NetherlandsDepartment of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The NetherlandsDepartment of Laboratory of Experimental Intensive Care and Anesthesiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Marianne A van de Pol Department of Respiratory Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The NetherlandsDepartment of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Wim Kulik Department of Genetic Metabolic Disorders, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Annemiek Dijkhuis Department of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Barbara S Smids Department of Respiratory Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The NetherlandsDepartment of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Hetty W van Eijk Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Jos A Karlas Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Richard Molenkamp Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Katja C Wolthers Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Sebastian L Johnston Airway Disease Infection Section, National Heart and Lung Institute, Imperial College London, London, UK PubMed articlesGoogle scholar articles
  • Jaring S van der Zee Department of Respiratory Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The NetherlandsDepartment of Respiratory Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Peter J Sterk Department of Respiratory Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • René Lutter Department of Respiratory Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The NetherlandsDepartment of Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • the RESOLVE research team
    Google scholar articles
  1. Correspondence to Dr K F van der Sluijs, Department of Laboratory of Experimental Intensive Care and Anesthesiology, P.O. Box 22700, Amsterdam 1100 DD, The Netherlands; kvandersluijs{at}amc.uva.nl
View Full Text

Citation

van der Sluijs KF, van de Pol MA, Kulik W, et al
Systemic tryptophan and kynurenine catabolite levels relate to severity of rhinovirus-induced asthma exacerbation: a prospective study with a parallel-group design
Thorax 2013;68:1122-1130.

Publication history

  • Received April 15, 2013
  • Revised June 21, 2013
  • Accepted June 30, 2013
  • First published July 23, 2013.
Online issue publication 
September 01, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions